Karl-Friedrich Kowalewski (@kfkowalewski) 's Twitter Profile
Karl-Friedrich Kowalewski

@kfkowalewski

Attending Urologist @UMM_Urology and Head of Junior research group -Intelligent Systems and Robotis in Urology- @DKFZ | Member @EAU_YAUroTech

ID: 734695152854392832

calendar_today23-05-2016 10:39:09

202 Tweet

394 Followers

351 Following

Juan Gómez Rivas (@jgomezrivas) 's Twitter Profile Photo

35 studies 27 studies on near-infrared fluorescence imaging (NIRF) using indocyanine green 4 studies on hyperspectral imaging 2 studies on folate-targeted molecular imaging 1 study each on optical coherence tomography and 5-aminolevulinic acid. Shorter warm ischemia time in

35 studies 
27 studies on near-infrared fluorescence imaging (NIRF) using indocyanine green
4 studies on hyperspectral imaging
2 studies on folate-targeted molecular imaging
1 study each on optical coherence tomography and 5-aminolevulinic acid. 

Shorter warm ischemia time in
Felix Bechtolsheim (@fxbech) 's Twitter Profile Photo

Wouldn't you like your surgeon to have trained before performing surgery? Our international survey aims to map and compare the reality of training in minimally invasive and robotic surgery globally. esurvey.uniklinikum-dresden.de/pub/index.php/… Find out more here and participate! SAGES is in Long Beach in 2025!

Wouldn't you like your surgeon to have trained before performing surgery? 

Our international survey aims to map and compare the reality of training in minimally invasive and robotic surgery globally.

esurvey.uniklinikum-dresden.de/pub/index.php/…

Find out more here and participate!
<a href="/SAGES_Updates/">SAGES is in Long Beach in 2025!</a>
Markus Eckstein (@markuseckstein3) 's Twitter Profile Photo

Oh my god …. They didn’t even took the time to adjust the legends after generating this !!published!! Image after AI generation. Where are we now … #Frontiers pushing the boundaries of fake science …

Oh my god …. They didn’t even took the time to adjust the legends after generating this !!published!! Image after AI generation. Where are we now … #Frontiers pushing the boundaries of fake science …
Kari Tikkinen (@karitikkinen) 's Twitter Profile Photo

"Evidence-based medicine in urology" at the #EAU24 🇫🇷 Session based on two Eur Urol Focus series of #EBM articles authored by the faculty - covers key aspects Welcome on Friday April 5 at 14:45 to Purple Area S03 Series 2 x.com/KariTikkinen/s… Series 1 x.com/KariTikkinen/s…

"Evidence-based medicine in urology" at the #EAU24 🇫🇷

Session based on two <a href="/EurUrolFocus/">Eur Urol Focus</a> series of #EBM articles authored by the faculty - covers key aspects

Welcome on Friday April 5 at 14:45 to Purple Area S03

Series 2 x.com/KariTikkinen/s…
Series 1 x.com/KariTikkinen/s…
Tom Powles (@tompowles1) 's Twitter Profile Photo

With Matt Galsky #EAU24 adjuvant nivolumab in bladder ca: HR 0.76 in ITT & 0.56 in PD-L1 +ve. Clinically meaningful results especially in PD-L1 +ves. No data on PD-L1-ve! OS is not yet significant but this data is impressive. ~60% relapse and 24% get subsequent IO. ~10% ⬆️tox.

With <a href="/MattGalsky/">Matt Galsky</a> #EAU24 adjuvant nivolumab in bladder ca: HR 0.76 in ITT &amp; 0.56 in PD-L1 +ve. Clinically meaningful results especially in PD-L1 +ves. No data on PD-L1-ve! OS is not yet significant but this data is impressive. ~60% relapse and 24% get subsequent IO. ~10% ⬆️tox.
Veeru Kasi (@veerukasi) 's Twitter Profile Photo

🚨 Breaking results 🚨 PRIME Trial UCL study presented at #EAU24 European Association of Urology (EAU). This 🌍 multicentre trial (n=555, 22 sites) showed that biparametric MRI without contrast is non-inferior 2 multiparametric MRI & should be the new standard for prostate cancer diagnosis if image quality is good

🚨 Breaking results 🚨 <a href="/PrimeMRI/">PRIME Trial UCL</a> study presented at #EAU24 <a href="/Uroweb/">European Association of Urology (EAU)</a>. This 🌍 multicentre trial (n=555, 22 sites) showed that biparametric MRI without contrast is non-inferior 2 multiparametric MRI &amp; should be the new standard for prostate cancer diagnosis if image quality is good
Michael Hofman (@drmhofman) 's Twitter Profile Photo

ENZA-P in The Lancet Oncology Lu-177 PSMA-617 + enzalutamide vs. enza alone: ● ↑PFS: 13.0 vs 7.8, hazard radio 0.43 ● PSA90 response 78% vs 37% ● PSA50 response 93% vs. 68% ● no additional side effects Incredible work from Louise Emmett Ian Davis & ANZUP team

ENZA-P in <a href="/TheLancetOncol/">The Lancet Oncology</a> 

Lu-177 PSMA-617 + enzalutamide vs. enza alone: 

● ↑PFS: 13.0 vs 7.8, hazard radio 0.43
● PSA90 response 78% vs 37%
● PSA50 response 93% vs. 68%
● no additional side effects

Incredible work from <a href="/drlouiseemmett/">Louise Emmett</a> <a href="/Prof_IanD/">Ian Davis</a> &amp; <a href="/ANZUPtrials/">ANZUP</a> team
European Urology (@euplatinum) 's Twitter Profile Photo

Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer Read the full article here: buff.ly/3QTtJet Annika Herlemann Matt Cooperberg #UroSoMe #Medtwitter #PCa

Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer

Read the full article here: buff.ly/3QTtJet 

<a href="/aherlema/">Annika Herlemann</a> <a href="/dr_coops/">Matt Cooperberg</a>

#UroSoMe #Medtwitter #PCa
Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 (@cacciamani_md) 's Twitter Profile Photo

#MachineLearning enables automated screening for systematic reviews and meta-analysis 📊Models optimized for sensitivity. ⏲️Training time ranged between 251-5834 s. 🔍Weighting approach performed best. 📉Misses of relevant studies were mostly zero. #ML #MA #Urology #Pub2Post

#MachineLearning enables automated screening for systematic reviews and meta-analysis 

📊Models optimized for sensitivity.
⏲️Training time ranged between 251-5834 s.
🔍Weighting approach performed best.
📉Misses of relevant studies were mostly zero.

#ML #MA #Urology #Pub2Post
Urology University Center Mannheim (@umm_urology) 's Twitter Profile Photo

Die molekularen Mechanismen von Blasenkrebs verstehen. Grundlagenforschung für Patienten erklärt. Eine Kooperation zwischen Urology University Center Mannheim und DKFZ Epigenetics, gefördert vom Hector Seed Funding Programm! Dank an ⁦Malin Nientiedt⁩ ⁦Manuel NManuel Rodríguez Paredes @filmhochdrei